Publicaciones (86) Publicaciones de ALFREDO RODRIGUEZ-ANTIGUEDAD ZARRANZ

2024

  1. Autoimmune-associated epilepsy in an outpatient epilepsy clinic: A retrospective study

    Neurology Perspectives, Vol. 4, Núm. 1

  2. Defining a standard set of health outcomes for patients with relapsing-remitting multiple sclerosis

    Multiple Sclerosis and Related Disorders, Vol. 84

  3. Early beginning of alemtuzumab: changing the multiple sclerosis treatment paradigm. Interim analysis of the LEMVIDA study

    Neurologia, Vol. 39, Núm. 5, pp. 383-391

  4. Value contribution of blood-based neurofilament light chain as a biomarker in multiple sclerosis using multi-criteria decision analysis

    Frontiers in Public Health, Vol. 12

2023

  1. Cost-Analysis of Subcutaneous vs Intravenous Administration of Natalizumab Based on Patient Care Pathway in Multiple Sclerosis in Spain

    PharmacoEconomics - Open, Vol. 7, Núm. 3, pp. 431-441

  2. Monitoring response to disease-modifying treatment in multiple sclerosis

    Neurology Perspectives, Vol. 3, Núm. 2

  3. Planificación familiar en hombres y mujeres con esclerosis múltiple. Análisis del Registro Andaluz (2018-2022)

    Revista de neurologia, Vol. 76, Núm. 12, pp. 377-383

  4. Therapeutic effect of α7 nicotinic receptor activation after ischemic stroke in rats

    Journal of Cerebral Blood Flow and Metabolism, Vol. 43, Núm. 8, pp. 1301-1316

  5. XV Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2022 (I)

    Revista de neurologia, Vol. 77, Núm. 1, pp. 19-30

  6. XV Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2022 (II)

    Revista de neurologia, Vol. 77, Núm. 2, pp. 47-60

2022

  1. Assessing care-related regret among nurses specialized in multiple sclerosis: A psychometric analysis of a new assessment battery

    Multiple Sclerosis Journal - Experimental, Translational and Clinical, Vol. 8, Núm. 4

  2. Consensus on early detection of disease progression in patients with multiple sclerosis

    Frontiers in Neurology, Vol. 13

  3. Consensus statement on the use of alemtuzumab in daily clinical practice in Spain

    Neurologia, Vol. 37, Núm. 8, pp. 615-630

  4. Disease modifying therapy switching in relapsing multiple sclerosis: A Delphi consensus of the demyelinating expert group of the Spanish society of neurology

    Multiple Sclerosis and Related Disorders, Vol. 63

  5. Neuropsychological Profile of Hereditary Ataxias: Study of 38 Patients

    Archives of Clinical Neuropsychology, Vol. 37, Núm. 5, pp. 904-915

  6. Sick leave and occupational burnout among nurses caring for patients with multiple sclerosis

    Multiple Sclerosis and Related Disorders, Vol. 63

2021

  1. Autoimmune encephalitis and related disorders: A retrospective study of 43 cases in a tertiary hospital

    Neurology Perspectives, Vol. 1, Núm. 4, pp. 197-205

  2. Behavioral aspects of nurse practitioners associated with optimal multiple sclerosis care in Spain

    PLoS ONE, Vol. 16, Núm. 12 December

  3. Four-year safety and effectiveness data from patients with multiple sclerosis treated with fingolimod: The Spanish GILENYA registry

    PLoS ONE, Vol. 16, Núm. 10 October

  4. Plasma determination of neurofilaments as biomarkers in multiple sclerosis: Conclusions of the EMotion Forum

    Revista de Neurologia, Vol. 73, Núm. 3, pp. 101-110